PTN News

  • PTN mentioned by Huffington Post blogger who offers global and longitudinal view of pediatrics research. May 12, 2016 Creating A Clinical Trial Strategy For Children’s Health Research by Russell Williams Over the past few decades, children’s health has arguably made some of the greatest gains. Infant mortality in most developed countries has fallen dramatically from an estimated 30 per cent to less than one per cent. Infectious diseases, the primary cause of infant mortality, have been ...
  • PTN lisinopril study and subsequent label change highlighted in DCRI News. May 12, 2016 Pediatric Trials Network study results in label change for hypertension drug May 11, 2016 – The change could affect the hundreds of children who are prescribed lisinopril after kidney transplants each year. A study conducted by the Pediatric Trials Network (PTN) has resulted in a labelling change for a widely used drug. Lisinopril is an angiotensin converting enzyme inhibitor that ...
  • PTN Gears up to Present at the 2016 Pediatric Academic Society (PAS) Meeting April 18, 2016 PTN Investigators to present abstracts at the PAS Meeting in Baltimore, April 30-May 3 Here’s a sampling of presentations with more to come: Platform Presentation: Sunday, May 1 at 4:15 PM–Dosing of antimicrobials in the neonatal in the NICU: Does clinical practice reflect published recommendations? M England, RG Greenberg, RH Clark, M Laughon, M Cohen-Wolkowiez, DK Benjamin Jr, and ...
  • NICHD Announces Research Funding Opportunity (U54) February 3, 2016 Specialized Centers in Research in Pediatric Developmental Pharmacology (U54)  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announces the re-competition of the Research in Pediatric Developmental Pharmacology Centers Program (RPDP).  The NICHD proposes to fund a limited number of research Centers that will provide an arena for multidisciplinary interactions between basic and clinical scientists interested in ...
  • Project babyTAPE Measures Up January 14, 2016 On December 18, 10 days ahead of schedule, the PTN babyTAPE team enrolled its 2,000th participant. On January 29, the babyTAPE databse was locked. The data collected in the babyTAPE study will be used to develop, design, and validate a weight estimation tool, similar to what is pictured, specific to infants. The study is chaired by Dr. Susan ...
  • Timolol for Infantile Hemangiomas under Review November 17, 2015 Since first reported in 2008 that propranolol, a beta blocker, was effective in the treatment of Infantile Hemangiomas (IH)—a birthmark that most commonly appears as a rubbery, bright red nodule of extra blood vessels in the skin, commonly called a “strawberry”—this class of drug has been used as the first line of therapy for infants ...
  • PTN Pantoprazole Study Closes Enrollment September 22, 2015 Congratulations to the PTN Pantoprazole Study Team for closing enrollment with 41 subjects. The study goal was to enroll 40 subjects in two age groups. The dedicated team worked hard to keep the study on track and accomplish this goal. The Pantoprazole Study will evaluate the pharmacokinetics of pantoprazole in obese children and adolescents with gastroesophageal reflux ...
  • 2015 Best Pharmaceuticals for Children Act Update July 2, 2015 Dear Colleagues: We would like to thank you for your continued interest and past input into the Best Pharmaceuticals for Children Act (BPCA) program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). As stakeholders in this important program, we would like to keep you abreast ...
  • PTN featured in the Wall Street Journal June 9, 2015 The Pediatric Trials made an appearance in the pages of the Wall Street Journal on June 8. Check out the story online: http://www.wsj.com/articles/how-much-of-a-drug-is-safe-for-preemies-1433784687.
  • PTN meropenem study published in the Federal Register May 28, 2015 The PTN marks another milestone as the Food and Drug Administration (FDA) has published a summary report of its pediatric study of meropenem in the Federal Register. Meropenem is a broad-spectrum anti-microbial drug often used to treat intra-abdominal infections in infants. The purpose of the PTN study, which began in the summer of 2008, was to ...